Use of cardiac CT amidst the COVID-19 pandemic and beyond: North American perspective.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 28 09 2020
revised: 06 11 2020
accepted: 10 11 2020
pubmed: 30 11 2020
medline: 4 3 2021
entrez: 29 11 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has affected patient care deliver throughout the world, resulting in a greater emphasis on efficiently and safety. In this article, we discuss the experiences of several North American centers in utilizing cardiac CT during the pandemic. We also provide a case-based overview which highlights the advantages of cardiac CT in evaluating the following scenarios: (1) patients with possible myocardial injury versus myocardial infarction; (2) patients with acute chest pain; (3) patients with stable chest pain; (4) patients with possible intracardiac thrombus; (5) patients with valvular heart disease. For each scenario, we also provide an overview of various societies recommendations which have highlighted the use of cardiac CT during different phases of the COVID-19 pandemic. We hope that the advantages of cardiac CT that have been realized during the pandemic can help promote wider adoption of this technique and improved coverage and payment by payors.

Identifiants

pubmed: 33248903
pii: S1934-5925(20)30476-7
doi: 10.1016/j.jcct.2020.11.004
pmc: PMC7661966
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-26

Informations de copyright

Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors of this manuscript have a conflict of interest relevant to this topic.

Auteurs

Vasvi Singh (V)

Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Cardiovascular Imaging Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, MA, USA.

Andrew D Choi (AD)

Division of Cardiology and Department of Radiology, The George Washington University School of Medicine, Washington, DC, USA.

Jonathon Leipsic (J)

Departments of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada.

Ayaz Aghayev (A)

Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

James P Earls (JP)

Division of Cardiology and Department of Radiology, The George Washington University School of Medicine, Washington, DC, USA.

Philipp Blanke (P)

Departments of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada.

Michael Steigner (M)

Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Leslee J Shaw Phd (LJ)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

Marcelo F Di Carli (MF)

Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Cardiovascular Imaging Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, MA, USA.

Todd C Villines (TC)

Division of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA, USA.

Ron Blankstein (R)

Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Cardiovascular Imaging Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, MA, USA. Electronic address: rblankstein@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH